KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival.

ABSTRACT:

SUBMITTER: Vendramini E 

PROVIDER: S-EPMC6756038 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature